Franklin Resources Inc Keros Therapeutics, Inc. Transaction History

Franklin Resources Inc

$313 Billion
Q2 2024

A detailed history of Franklin Resources Inc transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 400,214 shares of KROS stock, worth $26.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

400,214

Previous 632,049 36.68%

Holding current value

$26.9 Million

Previous $41.8 Million 56.29%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$44.58 - $66.89 $10.3 Million - $15.5 Million	-231,835 Reduced 36.68%	400,214 $18.3 Million
Q1 2024 May 13, 2024	SELL	$41.26 - $70.48 $2.78 Million - $4.75 Million	-67,376 Reduced 9.63%	632,049 $41.8 Million
Q4 2023 Feb 09, 2024	BUY	$27.12 - $41.05 $6.15 Million - $9.3 Million	226,674 Added 47.95%	699,425 $27.8 Million
Q4 2022 Feb 10, 2023	SELL	$39.45 - $51.77 $9,744 - $12,787	-247 Reduced 0.05%	472,751 $22.7 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $3,280 - $4,734	118 Added 0.02%	472,998 $17.8 Million
Q2 2022 Aug 11, 2022	BUY	$26.03 - $67.04 $2.04 Million - $5.24 Million	78,203 Added 19.81%	472,880 $13.1 Million
Q1 2022 May 13, 2022	SELL	$42.12 - $59.36 $463 - $652	-11 Reduced -0.0%	394,677 $21.5 Million
Q4 2021 Feb 11, 2022	BUY	$36.95 - $62.89 $1,034 - $1,760	28 Added 0.01%	394,688 $23.1 Million
Q3 2021 Nov 12, 2021	SELL	$29.27 - $43.71 $1,902 - $2,841	-65 Reduced 0.02%	394,660 $15.6 Million
Q2 2021 Aug 13, 2021	BUY	$42.4 - $70.11 $5.7 Million - $9.43 Million	134,546 Added 51.71%	394,725 $16.8 Million
Q1 2021 May 13, 2021	BUY	$54.0 - $75.28 $2,862 - $3,989	53 Added 0.02%	260,179 $16 Million
Q4 2020 Feb 10, 2021	BUY	$36.0 - $82.74 $9.36 Million - $21.5 Million	260,126 New	260,126 $18.3 Million

Others Institutions Holding KROS

# of Institutions

158

Shares Held

27.5M

Call Options Held

28.7K

Put Options Held

1.8K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.73B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Keros Therapeutics, Inc. Transaction History